BURLEIGH MEDICAL CENTRE
BURLEIGH STREET, BARNSLEYCKD 5
The percentage of patients on the CKD register with hypertension and proteinuria who are treated with an angiotensin coverting enzyme inhibitor (ACE-I) or angiotensin receptor blocker (AEB) (unless a contraindication or side effects are recorded)
Indicator | Year | Numerator | Denominator | Ratio | Centile |
---|---|---|---|---|---|
CKD 4 | 2007 | 47 | 78 | 60.3% | |
CKD 4 | 2008 | 59 | 107 | 55.1% | |
CKD 5 | 2009 | 9 | 16 | 56.2% | |
CKD 5 | 2010 | 11 | 15 | 73.3% | |
CKD 5 | 2011 | 18 | 22 | 81.8% | |
CKD 5 | 2012 | 16 | 18 | 88.9% | |
CKD 5 | 2013 | 18 | 20 | 90.0% | |
CKD003 | 2014 | 13 | 13 | 100.0% | |
CKD003 | 2015 | 14 | 14 | 100.0% | |
NM84 | 2016 | 10 | 13 | 76.9% | |
NM84 | 2017 | 11 | 15 | 73.3% | |
NM84 | 2018 | 12 | 20 | 60.0% | |
NM84 | 2019 | 11 | 20 | 55.0% | |
NM84 | 2020 | 7 | 14 | 50.0% | |
NM84 | 2022 | 4 | 9 | 44.4% | |
NM84 | 2023 | 2 | 6 | 33.3% |